Companion Biomarkers In Drug Development - 2013 Examines Companies That Are Actively Developing And Marketing Companion Biomarkers
DUBLIN, November 22, 2013 /PRNewswire/ --
Research and Markets ( http://www.researchandmarkets.com/research/6gr8mq/companion) has announced the addition of the "Companion Biomarkers in Drug Development" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Companion biomarkers are diagnostic tests that are specifically linked to a therapeutic drug either during its development or in the clinic. This linkage can be an important component of the drug development process; alternatively, the companion biomarker can be useful in ameliorating the regulatory process for the drug, or acting as an aid to therapeutic use in the clinic. Market opportunities for companion biomarkers are focused in drug development targets, drug development efficacy and clinical end points in four main therapeutic areas: oncology, cardiovascular, neurology and autoimmune. Using companion biomarkers yields safer and more efficacious drug products, reduces clinical trial and development costs, improves post-marketing safety profiles and salvages therapies that otherwise would not be granted approval. This report focuses on the role of companion diagnostic tests in drug development. It provides an in-depth discussion and analysis of the application of companion biomarkers to drug development and targeted therapeutics, as well as their use in clinical trials and the regulatory forum. The examination emphasizes new and developing technology platforms meant to aid in development of drugs for therapeutic use, and sometimes to be available as companion tests for these drugs in the clinic. Detailed tables and charts with sales forecasts and marketshare data are also included.
Companies Mentioned:- Abbott Laboratories - Affymetrix - Biomax Informatics - Compugen - Electric Genetics - Eli Lilly and Company - ePitope Informatics - Fujitsu - GlaxoSmithKline - Hologic Gen-Probe - IBM - INCOGEN, Inc - Ipsen - Jerini AG - Johnson & Johnson - Koada Technology - Luminex - Merck & Co, Inc - Novartis - Oracle - Oxonica - PamGene BV - Qiagen - Randox Laboratories- - Roche - Silicon Genetics - Thomson Reuters - Ventana Medical Systems - Wyeth - Zeptosens
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts